Big pharma bankrolls US cancer guideline authors

Most of the physicians who helped draw up key US oncology guidelines received money from big pharma, researchers say.

Of the 125 physicians who contributed to national guidelines on lung, breast, prostate and colorectal cancer, 108 had received over $30 million in funding from pharmaceutical companies.

The bulk of this money – almost $29 million -- was for research, but $1.25